Pantelis Skarlos

Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study

Florentia Fostira, Marianthi Tsitlaidou, Christos Papadimitriou et al. · Breast Cancer Research and Treatment · 2012 · 119 citations

Life Sciences, Genetics, Oncology +16

Protein expression patterns of cell cycle regulators in operable breast cancer

Flora Zagouri, Vassiliki Kotoula, George Kouvatseas et al. · PLoS ONE · 2017 · 43 citations · Full text

Medicine, Molecular Biology, Oncology +17

Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial

Helen Gogas, Urania Dafni, Henry Koon et al. · Journal of Translational Medicine · 2010 · 26 citations · Full text

Life Sciences, Immunology, Oncology +17

Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial

Pantelis Skarlos, C. Christodoulou, Konstantine T. Kalogeras et al. · Cancer Chemotherapy and Pharmacology · 2011 · 25 citations

Medicine, Oncology, Chemotherapy +15

Evaluation of the Insulin-like Growth Factor Receptor Pathway in Patients with Advanced Breast Cancer Treated with Trastuzumab

Christos Christodoulou, Georgios Oikonomopoulos, Georgia-Angeliki Koliou et al. · Cancer Genomics & Proteomics · 2018 · 17 citations · Full text

Medicine, Oncology, Pharmacotherapy +17